167 related articles for article (PubMed ID: 10853189)
1. Experimental study on paratumoral injection of cisplatin-loaded microspheres for gastric cancer.
Narita K; Ikuta H; Hamabe Y; Kuroda Y
Kobe J Med Sci; 1999 Oct; 45(5):229-43. PubMed ID: 10853189
[TBL] [Abstract][Full Text] [Related]
2. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic analysis of intra-peritoneal administration of cisplatin].
Terashima M; Ikeda K; Takagane A; Sasaki N; Abe K; Araya M; Nishizuka S; Yonezawa H; Irinoda T; Nakaya T; Oyama K; Saito K
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1859-62. PubMed ID: 9382551
[TBL] [Abstract][Full Text] [Related]
4. Prolonged local persistence of cisplatin-loaded gelatin microspheres and their chemoembolic anti-cancer effect in rabbits.
Ohta S; Nitta N; Sonoda A; Seko A; Tanaka T; Takahashi M; Takemura S; Tabata Y; Murata K
Eur J Radiol; 2009 Dec; 72(3):534-40. PubMed ID: 18778907
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of platinum accumulation in gastric cancer after preoperative intra-arterial injection of cisplatin].
Itoh A; Taniguchi H; Daidoh T; Tsukuda N; Shioaki Y; Seiki K; Yokota T; Yamane T; Yamaguchi T; Sawai K
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2722-5. PubMed ID: 2782884
[TBL] [Abstract][Full Text] [Related]
6. An experimental study of regional chemotherapy using CDDP-loaded microspheres for esophageal cancer.
Nakamura Y; Hamabe Y; Ikuta H; Hyon SH; Kuroda Y
Surg Today; 2002; 32(4):335-42. PubMed ID: 12027199
[TBL] [Abstract][Full Text] [Related]
7. [Studies on preparation and characteristics of cisplatin chitosan microspheres].
Wang YM; Shi TS; Pu YL; Zhu JG; Zhao YL
Yao Xue Xue Bao; 1996; 31(4):300-5. PubMed ID: 9208650
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
[TBL] [Abstract][Full Text] [Related]
9. Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting.
Huo D; Deng S; Li L; Ji J
Int J Pharm; 2005 Jan; 289(1-2):63-7. PubMed ID: 15652199
[TBL] [Abstract][Full Text] [Related]
10. [Intracavitary microspheres incorporating cisplatinum in the treatment of malignant effusions--clinical trials].
Hagiwara A; Takahashi T; Yamaguchi T; Taniguchi H; Iwamoto A; Yoneyama C; Ito M; Sasabe T; Lee M; Wada R
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1575-8. PubMed ID: 2389951
[TBL] [Abstract][Full Text] [Related]
11. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
Koizumi W; Kurihara M; Hasegawa K; Chonan A; Kubo Y; Maekawa R; Iwasaki R; Sasai T; Fukuyama Y; Ishikawa K; Miyoshi K; Yasutake K; Hayakawa M
Oncol Rep; 2004 Sep; 12(3):557-61. PubMed ID: 15289837
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
Mok TS; Kanekal S; Lin XR; Leung TW; Chan AT; Yeo W; Yu S; Chak K; Leavitt R; Johnson P
Cancer; 2001 Jun; 91(12):2369-77. PubMed ID: 11413527
[TBL] [Abstract][Full Text] [Related]
13. Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice.
Júnior AD; Mota LG; Nunan EA; Wainstein AJ; Wainstein AP; Leal AS; Cardoso VN; De Oliveira MC
Life Sci; 2007 Jan; 80(7):659-64. PubMed ID: 17141809
[TBL] [Abstract][Full Text] [Related]
14. Reduction of systemic exposure and toxicity of cisplatin by encapsulation in poly-lactide-co-glycolide.
Verrijk R; Smolders IJ; Bosnie N; Begg AC
Cancer Res; 1992 Dec; 52(23):6653-6. PubMed ID: 1423309
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin.
Tian J; Pang X; Yu K; Liu L; Zhou J
Pharmazie; 2008 Aug; 63(8):593-7. PubMed ID: 18771008
[TBL] [Abstract][Full Text] [Related]
16. [Experimental studies on drug concentrations in the liver using intra-hepatic injection of anticancer drug in combination with temporary halting of abdominal blood flow].
Nishioka Y; Iwama T; Ishida H; Fukunari H; Yamazaki T; Okubo Y; Imajo M; Mishima Y; Endo S
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1736-9. PubMed ID: 2389961
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials with intraperitoneal cisplatin microspheres for malignant ascites--a pilot study.
Hagiwara A; Takahashi T; Sawai K; Sakakura C; Tsujimoto H; Osaki K; Sakakibara T; Ohyama T; Ohgaki M; Muranishi S
Anticancer Drug Des; 1993 Dec; 8(6):463-70. PubMed ID: 8286013
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous intratumoral injection of cisplatin microspheres in tumor-bearing rats to diminish acute nephrotoxicity.
Kuang L; Yang DJ; Inoue T; Liu WC; Wallace S; Wright KC
Anticancer Drugs; 1996 Feb; 7(2):220-7. PubMed ID: 8740729
[TBL] [Abstract][Full Text] [Related]
19. [Studies on hepatic arterial embolization with cisplatin-chitosan-microspheres in dogs].
Wang YM; Shi TS; Pu YL; Zhu JG; Zhao YL
Yao Xue Xue Bao; 1995 Dec; 30(12):891-5. PubMed ID: 8712014
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of hypotonic cisplatin chemotherapy administered into the peritoneal and the pleural cavities in experimental model.
Katano K; Tsujitani S; Oka S; Saito H; Gomyo Y; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 2000; 20(3A):1603-7. PubMed ID: 10928078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
